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α-Gal on the protein surface 
affects uptake and degradation 
in immature monocyte derived 
dendritic cells
M. Krstić Ristivojević1,2, J. Grundström1, T. A. T. Tran1, D. Apostolovic1, V. Radoi3, 
M. Starkhammar4, V. Vukojević  3, T. Ćirković Veličković2,5, C. Hamsten1 & M. van Hage1
Red meat allergy is characterized by an IgE response against the carbohydrate galactose-α-1,3-
galactose (α-Gal), which is abundantly expressed on glycoproteins from non-primate mammals. The 
mechanisms of how α-Gal is processed and presented to the immune system to initiate an allergic 
reaction are still unknown. The aim of this study was to reveal whether the presence of α-Gal epitopes 
on the protein surface influence antigen uptake and processing in immature monocyte-derived dendritic 
cells (iMDDCs). Immature MDDCs were prepared from healthy blood donors and red meat allergic 
patients. We found an increased internalization of α-Gal carrying proteins over time in iMDDCs by flow 
cytometric analysis, which was independent of the donor allergic status. The uptake of α-Gal carrying 
proteins was significantly higher than the uptake of non-α-Gal carrying proteins. Confocal microscopy 
revealed α-Gal carrying proteins scattered around the cytoplasm in most iMDDCs while detection of 
proteins not carrying α-Gal was negligible. Fluorescent detection of protein on SDS-PAGE showed that 
degradation of α-Gal carrying proteins was slower than degradation of non-α-Gal carrying proteins. 
Thus, the presence of α-Gal on the protein surface affects both uptake and degradation of the protein, 
and the results add new knowledge of α-Gal as a clinically relevant food allergen.
Allergy to red meat presents as a delayed early phase allergic reaction, usually 3–6 hours after red meat consumption1–3. 
The reaction is due to IgE antibodies toward the oligosaccharide galactose-α-1,3-galactose (α-Gal)1–4, which 
is expressed on non-primate mammalian proteins. In humans and higher primates, the gene encoding α-1, 
3-galactosyltransferase is non-functional and thus α-Gal is not expressed5. Induction of red meat allergy has 
been linked to tick bites in many parts of the world and α-Gal has shown to be present in ticks4,6–8, but the mech-
anism of sensitization is still unknown. The unusually long delay of symptoms is also not fully understood, but is 
presumably linked to delayed appearance of the antigen in the bloodstream and/or processing by dendritic cells 
(DCs) and T-cells.
Dendritic cells are professional antigen presenting cells and immature DCs are sampling the environment 
to capture antigens and initiate an adaptive immune response by activating and priming naive CD4+ T-cells9. 
The subsequent outcome of this interaction can be tolerance promotion or induction of active immunity10. 
Internalization and degradation of antigens by DCs are important steps in determining whether an antigen 
will be treated as dangerous or innocuous11. Antigens can be actively internalized in several different ways: 
receptor-mediated endocytosis, macropinocytosis and phagocytosis12. After uptake, the vesicle formed fuses with 
endosomal compartments where the antigens will be processed into peptides that can be further presented on 
the cell surface.
In this study we investigated whether the presence of allergenic α-Gal epitopes on the protein surface affects 
internalization by immature monocyte derived DCs (iMDDC). Furthermore, we analyzed the uptake in iMDDCs 
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from both healthy blood donors and red meat allergic patients, as well as the effect of protein size and type of 
carbohydrate on protein uptake.
Results
α-Gal glycosylation influences protein uptake. Uptake of fluorescently labeled α-Gal and non-α-Gal 
carrying proteins by iMDDCs differentiated from healthy individuals was analyzed after 1, 2 and 4 h. 
Accumulation of bovine serum albumin carrying α-Gal (BSA-α-Gal) was observed over time (p = 0.0107, from 
1 h to 4 h) and internalization of BSA-α-Gal was significantly higher compared to internalization of BSA at all 
three time points (p < 0.0001, Fig. 1A). Similarly, uptake of human serum albumin carrying α-Gal (HSA-α-Gal) 
was significantly higher compared to the uptake of HSA (p < 0.0001 at all time points), and internalization of both 
proteins increased over time (HSA-α-Gal: p < 0.0001 from 1 to 4 h and p = 0.0002 from 2 to 4 h, HSA: p = 0.0441 
from 1 to 2 h, < 0.0001 from 1 to 4 h and 0.0127 from 2 to 4 h, Fig. 1B). Uptake of fluorescently labeled BSA-α-Gal 
and BSA by iMDDCs from four red meat allergic patients was analyzed after 4 h of incubation. Comparably to 
healthy individuals, BSA-α-Gal was internalized to a significantly higher degree than BSA (p = 0.0013, Fig. 1C).
To investigate whether protein size and the type of carbohydrate modification carried by the protein affect 
iMDDC uptake, cells from healthy donors were also stimulated with bovine thyroglobulin (bTG), with a 
Figure 1. Time dependent uptake of (A) BSA-α-Gal and BSA, n = 10, and (B) HSA-α-Gal and HSA, n = 8, 
by iMDDCs generated from healthy donors. *p < 0.05, and ***p < 0.001 analyzed by two-way ANOVA with 
Bonferroni’s post hoc test. (C) Uptake of BSA-α-Gal and BSA by iMDDCs generated from red meat allergic 
patients after 4 h of incubation, n = 4. **p < 0.001 analyzed by paired t-test.
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molecular weight 10 times higher than BSA-α-Gal, and BSA-N-Acetyllactosamine (NAl), a carbohydrate mod-
ification with similar size as α-Gal. (Fig. 2). Uptake of bTG was comparable to uptake of BSA-α-Gal, showing 
significantly higher uptake compared to BSA at 1 and 4 h (p < 0.0001, Fig. 2A). However, the uptake of BSA-NAl 
was comparable to BSA and significantly lower compared to the uptake of BSA-α-Gal after 1 and 4 h of incubation 
(p < 0.0001, Fig. 2B).
Inhibition of internalization routes. The uptake of α-Gal carrying proteins was confirmed to be an 
active process, since internalization was significantly reduced by incubating the cells at 4 °C for 4 h (BSA-α-Gal, 
p = 0.0017, and BSA, p = 0.0165, Supplementary Fig. S1A). To analyze by which route α-Gal carrying proteins 
are internalized, the inhibitory agents cytochalasin D (CytD), which inhibits macropinocytosis, and monodan-
sylcadaverine (MDC), which inhibits receptor-mediated endocytosis, were added to the iMDDC cultures 30 min 
before addition of BSA-α-Gal or BSA. Incubation of iMDDCs with both CytD and MDC inhibited the internali-
zation of BSA-α-Gal and BSA at 1 h (CytD: BSA-α-Gal, p = 0.0001, and BSA, p = 0.0397, and MDC: BSA-α-Gal, 
p = 0.0001, and BSA, p = 0.0385, Fig. 3) and 4 h (CytD: BSA-α-Gal, p = 0.0156, and BSA, p = 0.0327, and MDC: 
BSA-α-Gal, p < 0.0001, and BSA, p = 0.0018, Supplementary Fig. S1B and C).
The α-Gal epitope can be detected in iMDDC lysates. Immature MDDC lysates from cells harvested 
at different time points were analyzed by SDS PAGE and Western blot for the presence of the α-Gal epitope. 
Detection of fluorescently labeled proteins showed a band above 75 kDa that was present for up to 16 h of uptake 
of BSA-α-Gal (Fig. 4A). After 4, 6 and 8 h of BSA-α-Gal incubation, a protein band lower than the intact protein 
was detected, which probably represents degraded products of the protein. For BSA, a strong protein band was 
detected for up to 6 h of uptake (Fig. 4A). Western blot analysis confirmed that the α-Gal epitope was present in 
cell lysates from iMDDCs incubated with BSA-α-Gal for up to 16 h (Fig. 4B). For size comparison, the pure pro-
teins (BSA and BSA-α-Gal) were separated onto 12% polyacrylamide gel via SDS-PAGE (Supplementary Fig. S3).
α-Gal containing proteins are scattered in the cytoplasm of iMDDCs. Confocal laser scanning 
microscopy imaging revealed that after 1 h of incubation, BSA-α-Gal was present at detectable levels in the cyto-
plasm in about 50% of the iMDDCs. After 4 h of incubation it was observed in all cells, with a prevalent localiza-
tion in the perinuclear region (Fig. 5, green). In contrast, BSA uptake by iMDDCs was not detected, either after 1 
or 4 h of incubation, evidenced by the lack of green signal (Fig. 5). Observations made by imaging confirmed the 
flow cytometric analysis. There was no detectable uptake of BSA-NAl after 1 and 4 h of incubation, whereas after 
1 and 4 h of incubation with the α-Gal containing protein bTG, the fluorescently labeled protein was scattered in 
the cytosol of almost all iMDDCs (Supplementary Fig. S4).
Figure 2. The impact of protein size and conjugation on protein uptake. The uptake of bTG compared to the 
uptake of BSA-α-Gal and BSA. (B) The uptake of BSA-NAl compared to the uptake of BSA-α-Gal and BSA. 
iMDDCs were generated from healthy blood donors, n = 4. ***p < 0.001 analyzed by two-way ANOVA with 
Bonferroni’s post hoc test.
Figure 3. Inhibition of internalization of BSA-α-Gal and BSA in healthy iMDDCs after 1 h of incubation by 
(A) Cytochalasin D, n = 6 (BSA-α-Gal) and n = 5 (BSA), and (B) Monodansylcadaverine, n = 7. *p < 0.05, 
***p < 0.001 analyzed by paired t-test.
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Figure 4. (A) Fluorescent detection of BSA-α-Gal and BSA in iMDDCs lysates resolved on an SDS-
polyacrylamide gel. (B) Western blot detection of the α-Gal epitope in lysates from iMDDCs. iMDDCs were 
generated from healthy blood donors and unstimulated cells were used as control. Full length gels and blot are 
presented in Supplementary Fig. S2.
Figure 5. Uptake of BSA-α-Gal (left) and BSA (right) after 1 h (top) and 4 h (bottom) of iMDDC incubation 
at 37 °C analyzed by confocal laser scanning microscopy. Green = BSA-α-Gal or BSA, red = HLA-DR and 
blue = DAPI stained nuclei.
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Discussion
α-Gal rich foods elicit delayed allergic symptoms in red meat-allergic patients, which could be due to uptake 
and processing by dendritic cells. In the present study we show efficient uptake of the α-Gal model antigens 
BSA-α-Gal and HSA-α-Gal by in vitro cultured human iMDDCs. Similar results were obtained for iMDDCs gen-
erated from healthy individuals and red meat allergic patients, indicating that altered uptake of α-Gal in dendritic 
cells per se is not a factor contributing to red meat allergy. However, DCs are likely involved in the sensitization 
phase of red meat allergy where α-Gal containing proteins may be taken up in the close vicinity of a tick bite. In 
atopic individuals the DCs may then initiate allergic sensitization through skewing of CD4+ T cells towards a Th2 
response. A recent report showed that the context of allergen uptake is important for maturation of iMDDCs and 
that the maturation effect differed between healthy and atopic donors13.
Interestingly, the uptake of BSA and HSA alone was not as efficient as for their α-Gal carrying counterparts. 
Thus, the presence of α-Gal on the surface seems to enhance internalization of the protein, suggesting an α-Gal 
dependent uptake mechanism. The results are in line with previous studies on glycosylated protein uptake, where 
a 100-fold higher uptake of mannosylated BSA compared with non-mannosylated BSA was demonstrated14. 
Furthermore, advanced glycation end products of ovalbumin were taken up more efficiently by iMDDCs com-
pared with ovalbumin15.
We also investigated if the size and conjugation of the proteins have impact on the uptake. Immature MDDCs 
from healthy individuals showed no difference in the uptake of BSA-α-Gal and bTG even though the molecular 
weight of bTG is approximately 10 times higher than the molecular weight of BSA-α-Gal. Interestingly, the uptake 
of BSA-NAl was several times lower compared to BSA-α-Gal, even though the α-Gal and NAl carbohydrates are 
of similar size. Previous studies have shown that MDDCs internalize BSA with different glycosylation patterns to 
very varying extent16, and for other glycosylated allergens the mannose receptor plays a major role in glycoaller-
gen recognition and uptake17. Our results strongly suggest that the specific glycosylation of protein antigens pre-
dominantly influence the uptake, while the size is not a decisive factor. This is in line with previous studies which 
have shown that human DCs, in addition to protein antigens, are able to internalize large size particles18 while the 
key factor that influence protein uptake is the surface architecture14.
We next elucidated whether α-Gal could be detected in the cytoplasm of iMDDCs. Fluorescence detec-
tion confirmed the presence of BSA-α-Gal in iMDDC cytoplasm. Moreover, SDS PAGE analysis showed that 
BSA-α-Gal was detected after up to 16 h of incubation, while BSA was only detected up to 6 h. Western blot with 
monoclonal anti-α-Gal antibody confirmed that the BSA-α-Gal still carries the epitope. Our results suggest that 
the degradation pathway of α-Gal carrying proteins is slower than for non-carrying proteins and that they are 
stored intact inside of cells. Most likely the α-Gal glycosylation protects the protein from degradation and as such 
may increase the processing time and exposure on the surface of the cell. Other studies have indeed shown that 
reduced degradation increases antigen presentation on MHCII19 and that the allergenic Bet v 1a was degraded 
slower than its hypoallergenic isoform Bet v 1d20, suggesting that processing time affects allergenicity. This is also 
in line with the delayed appearance of symptoms in red meat allergic patients.
The route of internalization was analyzed by adding CytD and MDC to the iMDDC cultures which resulted in 
a partial inhibition of the internalization of BSA, regardless of the presence of α-Gal. The inhibition was stronger 
after 1 h of incubation than after 4 h, which probably reflects a temporary effect by both inhibitory agents. MDC 
blocks receptor-mediated endocytosis whereas CytD affects invagination of the cell membrane by blocking actin 
polymerization, which inhibits macropinocytosis and phagocytosis21. However, blocking of actin polymerization 
may also inhibit receptor-mediated endocytosis21. Fluorescently labeled BSA can be used for measuring uptake 
via macropinocytosis, but as with chemical inhibition of antigen-uptake, it is difficult to unambiguously distin-
guish between macropinocytosis and receptor-mediated endocytosis as the uptake mechanism in DCs22. Our 
results thus indicate that both receptor-mediated endocytosis and macropinocytosis are involved in the uptake 
of α-Gal containing proteins.
The confocal analysis revealed accumulated BSA-α-Gal and bTG after 1 and 4 h of incubation, whereas no 
internalization of BSA and BSA-NAl could be detected at any time point. Thus, for antigen uptake the conjugated 
sugar seems to be more important than the protein size, in line with the flow cytometric analysis. After 1 h the 
proteins were found in clusters scattered around the cytoplasm while after 4 h, the proteins were found closer to 
the nucleus, suggesting that BSA-α-Gal is taken up and processed in endosomes.
In conclusion, α-Gal containing proteins are actively and promptly internalized by iMDDCs in a 
time-dependent manner, and the mechanism of internalization seems to be α-Gal dependent. Thus, α-Gal on 
the protein surface affects uptake and processing of the protein, and the results add new knowledge of α-Gal as a 
clinically relevant food allergen.
Methods
Reagents. BSA, HSA, bTG, MDC and CytD were obtained from Sigma-Aldrich (Saint Louis, MO, USA). 
BSA-α-Gal, HSA-α-Gal, and BSA-NAl were obtained from Dextra Laboratories (Reading, UK).
Fluorescent labelling of proteins. BSA, BSA-α-Gal, BSA-NAl, HSA, HSA-α-Gal and bTG were fluo-
rescently labeled with Alexa Fluor 488 (AF 488) using the protein labelling kit (Thermo Fisher, Rockford, IL, 
US) according to the manufacturer’s instructions. Protein concentration was determined using the bicinchoninic 
acid protein assay kit (Life technologies, Carlsbad, CA, USA) according to the manufacturer’s instructions. The 
endotoxin levels were determined by the limulus amebocyte lysate assay (Charles River Endosafe, Charleston, SC, 
USA) to less than 1 ng LPS/mg of protein in all protein preparations. The labeled proteins were stored at −20 °C 
and protected from light until further use.
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Donors and patients. Buffy coats from 18 healthy blood donors and four patients diagnosed with red meat 
allergy by a physician experienced in allergic diseases were included in the study.
Ethics Statement. The study was approved by the local ethics committee (2014/847-32 and 2016/1447-32) 
and all experiments were in accordance with relevant guidelines and regulations. Sample collection was done after 
written informed consent from the study participants.
Cell isolation and culturing. Peripheral blood mononuclear cells were isolated by density gradient cen-
trifugation using Ficoll–Paque (GE Healthcare, Uppsala, Sweden). CD14+ monocytes were isolated by magnetic 
bead separation (Miltenyi Biotec, Bergisch Gladbach, Germany) in accordance with the manufacturer’s instruc-
tions. Immature MDDCs were generated as previously described23. For uptake analysis, iMDDCs were seeded 
in multiwell flat-bottom tissue culture plates and incubated with 10 µg/106 cells of fluorescently labeled proteins 
for 1, 2 and 4 h. Internalization was inhibited by incubating the iMDDCs at 4 °C, or by adding MDC (200 µM) or 
CytD (2 µM) 30 min before adding the proteins for each time point. In all experiments, untreated iMDDCs were 
used as negative control.
Flow cytometry. Cells were harvested after incubation with AF 488 labeled proteins and stained with LIVE/
DEAD Aqua stain (Molecular probes, Thermo Fisher) or fixable viability stain 780 (BD Bioscience, San Jose, 
Calif., US). After this, the samples were fixed with 2% PFA and surface markers (CD11c-PE-Cy7 (clone B-ly6), 
CD14-APC (clone M5E2), both from BD Bioscience) were stained. At least 10′000 single cell events (according 
to the gating strategy, Supplementary Fig. S5) were collected on a FACSCanto II flow cytometer using the BD 
FACS Diva software (BD Bioscience). Data analysis was performed using FlowJo version 10 software (FlowJo 
LLC, Oregon, US).
SDS-PAGE and Immunoblot analysis of α-Gal proteins. After incubation with AF 488 labeled BSA 
and BSA-α-Gal for 1, 2, 4, 6, 8 and 16 h, iMDDCs were pelleted and the cell pellets were treated with radioimmu-
noprecipitation lysis buffer. Unstimulated cells were used as control. The lysates were clarified by centrifugation 
and the soluble fractions were separated by SDS-PAGE under reducing conditions. Intracellular AF 488 labeled 
proteins were visualized on a ChemiDoc system (Bio-Rad, Hercules, CA, US). Following visualization, resolved 
proteins were transferred to polyvinylidene difluoride membranes (0.2 µm pore size) using a Bio-Rad turbo sys-
tem. The membranes were probed with a previously validated24 monoclonal anti-α-Gal antibody (M86, Enzo 
Life Sciences, Farmingdale, NY, USA) followed by alkaline phosphatase labeled goat anti-mouse IgM antibody 
(Southern Biotech, Birmingham, AL, USA). Immunoreactive bands were visualized using nitro blue tetrazolium 
and 5-bromo-4-chloro-3-indolyl phosphate substrates (Bio-Rad).
Confocal Laser Scanning Microscopy. iMDDCs were cultured for 1 h at 37 °C on coverslips coated with 
poly-L-lysine (Neuvitro Corporation, WA, USA) to allow cell attachment. After 1 and 4 h of incubation with AF 
488 labeled proteins (10 µg/106 cells), the coverslips were washed with PBS and stained with purified anti-human 
HLA-DR antibody (clone L243, BioLegend, San Diego, CA, USA), followed by a secondary goat anti-mouse 
IgG antibody conjugated with AF 555 (clone Poly4053, BioLegend). The coverslips were mounted using Prolong 
Gold Antifade reagent with DAPI (Molecular probes). Confocal Laser Scanning Microscopy (CLSM) was per-
formed using the LSM 510 Meta system (Carl Zeiss, Jena, Germany) individually modified to allow imaging 
with improved detection efficiency using avalanche photodiodes25. The alpha Plan-Fluar 100 ×/1.45 oil immer-
sion objective (Zeiss MicroImaging GmbH, Jena, Germany) was used throughout. Images were acquired at 
1024 × 1024 pixel resolution, scanning speed 12.6 µs/pixel, without averaging, and prepared for publication using 
the Zeiss LSM Image Browser software.
Statistical analysis. Data are presented as mean value ± s.e.m. Differences in protein uptake at the same 
time point were analyzed by two-way ANOVA using Bonferroni post hoc test. Differences in protein uptake at 
different time points were analyzed by two-way ANOVA using Tukey post hoc test. The effect of inhibition and 
uptake for red meat allergic patients was analyzed by paired two-tailed t-test. Differences were considered signif-
icant if P < 0.05. For statistical analysis GraphPad Prism version 6.00 software for Windows (GraphPad Software, 
La Jolla, CA, USA) was used.
Data availability. No datasets were generated or analyzed during the current study.
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